Key result
Perioperative increases in high-sensitivity cardiac troponin T above preoperative values were associated with a higher risk of 30-day mortality and MACCE (adjusted OR 2.9; 95% CI 1.8-4.7).
Why the study?
Patients with perioperative myocardial injury face increased risk of death and MACCE, prompting the need to determine optimal hs-cTnT thresholds to predict these outcomes.
Does perioperative hs-cTnT surveillance improve prediction of 30-day mortality and MACCE compared to the Revised Cardiac Risk Index in patients ≥50 years undergoing elective major noncardiac surgery?
Cohort
Yes
Does perioperative hs-cTnT surveillance improve prediction of 30-day mortality and MACCE compared to the Revised Cardiac Risk Index in patients ≥50 years undergoing elective major noncardiac surgery?
Odds Ratio: 2.9 (95% CI 1.8–4.7)
Perioperative hs-cTnT surveillance provides a net prognostic benefit over the Revised Cardiac Risk Index for identifying patients at high risk of 30-day death and MACCE after major noncardiac surgery.
May support troponin thresholds for postoperative risk stratification beyond RCRI; leaves open whether surveillance improves outcomes.
BACKGROUND: Patients with perioperative myocardial injury are at risk of death and major adverse cardiovascular and cerebrovascular events (MACCE). The primary aim of this study was to determine optimal thresholds of preoperative and perioperative changes in high-sensitivity cardiac troponin T (hs-cTnT) to predict MACCE and mortality. METHODS: Prospective, observational, cohort study in patients ≥50 yr of age undergoing elective major noncardiac surgery at seven hospitals in Sweden. The exposures were hs-cTnT measured before and days 0-3 after surgery. Two previously published thresholds for myocardial injury and two thresholds identified using receiver operating characteristic analyses were evaluated using multivariable logistic regression models and externally validated. The weighted comparison net benefit method was applied to determine the additional value of hs-cTnT thresholds when compared with the Revised Cardiac Risk Index (RCRI). The primary outcome was a composite of 30-day all-cause mortality and MACCE. RESULTS: above preoperative values provided statistically optimal model performance and was associated with the highest risk for the primary outcome (adjusted odds ratio 2.9, 95% confidence interval 1.8-4.7). Validation in an independent, external cohort confirmed these findings. A net benefit over RCRI was demonstrated across a range of clinical thresholds. CONCLUSIONS: above baseline values identifies acute perioperative myocardial injury and provides a net prognostic benefit when added to RCRI for the identification of patients at high risk of death and MACCE. CLINICAL TRIAL REGISTRATION: NCT03436238.
No takes yet. Share an insight, caveat, or question.
Chew et al. (2021) conducted a cohort in Elective major noncardiac surgery. Perioperative changes in high-sensitivity cardiac troponin T (hs-cTnT) vs. Preoperative values / Revised Cardiac Risk Index (RCRI) was evaluated on Composite of 30-day all-cause mortality and MACCE (adjusted OR 2.9, 95% CI 1.8-4.7). Perioperative increases in high-sensitivity cardiac troponin T above preoperative values were associated with a higher risk of 30-day mortality and MACCE (adjusted OR 2.9; 95% CI 1.8-4.7).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: